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A B S T R A C T  
 
Renal artery stenosis is one common clinical problem. It has wide spectrum of 
pathophysiology with 3 most common clinical syndromes, ischemic nephropathy, 
hypertension, and cardiac destabilization syndrome. Aim: To date there was not any specific 
diagnostic criteria for renal artery stenosis. Method: Clinicians only used some clinical 
syndromes to guide the diagnostic possibility of renal artery stenosis. RADUS as one 
sensitive and specific diagnostic method, still had some disadvantages. Results: it gives false 
negative results in 10-20% of patients due to confounding factors such as operator 
capability, obesity, or abdominal gas distribution. CTA and MRA was excellent, but possessed 
some risks for the patient. Therefore, CTA was mostly recommended in patient with the 
planning of revascularization. Management of renal artery stenosis was still debated 
between optimal medical management and revascularization because the complexities of 
mechanisms underlying the renal artery stenosis. Because of the complicated 
pathophysiology of renal artery stenosis, revascularization could not entirely improve 
renovascular hypertension and nephropathy. Revascularization offered best results in 
fibromuscular dysplasia, although procedure related complication was still high. 
Revascularization, even though it might have high success rate in atherosclerotic renal 
artery stenosis, but the incidence of re-stenosis was also fairly high. Conclusion: Overall, 
revascularization was recommended in FMD, but should only be preserved for 
atherosclerotic renal artery stenosis after the failure of optimal medical management. 
 
Keywords: renal artery stenosis, diagnosis, medical management, 
revascularization 
  
I N T R O D U C T I O N 
Renal artery stenosis becomes a 
substantial clinical problem especially in 
countries with poor resources. Generally, 
renal artery stenosis was categorized into 
atherosclerotic and non-atherosclerotic renal 
artery stenosis. 90% of renal artery stenosis 
was caused by atherosclerosis. Non-
atherosclerotic renal artery stenosis was 
mostly caused by fibromuscular dysplasia 
which composed 10% of all renal artery 
stenosis.[1,2] Diagnosis of renal artery stenosis 
is important because it could decrease renal 
blood flow and renal perfusion. Severe renal 
artery stenosis could activate the renin 
angiotensin aldosterone system. It would 
induce vasoconstriction and increase of 
peripheral artery resistance.[1,3,4] Literatures 
suggest the relationship between renal artery 
stenosis and reno-vascular hypertension. 
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Renal artery stenosis includes a wide 
spectrum of pathophysiology with 3 most 
common clinical syndromes, ischemic 
nephropathy, hypertension, and cardiac 
destabilization syndrome.[2] To date, there are 
not any diagnostic criteria for renal artery 
stenosis. Some authors suggested clinical 
suspicion as a guide for diagnosing renal 
artery stenosis.[1,5] Renal artery duplex 
ultrasonography is recognized as a sensitive 
diagnostic method for renal artery stenosis, 
although there are still many confounding 
factors. It gave negative results in 10-20% of 
cases. Another imaging examination such as 
CTA (computerized tomography angiography) 
and MRA (magnetic resonance angiography), 
although highly sensitive and specific, both are 
expensive and inflict contrast and radiation 
exposure.[5,6]  
Recently, studies indicated renal artery 
revascularization did not improve patients’ 
outcomes in the aspects of renal function and 
cardiovascular outcomes.[7] Angioplasty and 
stenting procedures offered excellent results 
for fibromuscular dysplasia, but evidence was 
not enough to prove benefit for blood pressure 
control and renal function improvement. Both 
procedures also possessed high prevalent 
risks and did not provide any prevention from 
cardiovascular risk.[8,9] This review article 
explained about problems in the diagnosis and 
management of renal artery stenosis, 
especially in the setting of poor resources.  
Renal Vascularization and Glomerular 
Filtration Regulation 
Kidney worked as a unit of excretion. 
Beside excreting residual substances such as 
ammonia, urea, creatinine, and uric acid, it also 
excretes drugs and toxin. Kidney has another 
function as regulator of water and electrolyte 
equilibrium. It regulates the balance of acid 
base, calcium, phosphate, vitamin D 
metabolism, and red blood cell production. 
Every nephron in kidney contains glomerulus, 
which function as ultrafiltration membrane, 
loop of Henle, distal renal tubules, and 
collective tubules.[4,8]   
Blood flows through afferent arterioles 
to glomerular capillaries. In the glomerulus, 
capillaries rolled up densely, surrounded by 
Bowman capsules. Blood in glomerulus 
undergo ultrafiltration in glomerular 
basement membrane (GBM), which consisted 
of basal membrane of tubular epithelia and 
vascular endothelial cells. Majority of water-
soluble substances will be filtrated through 
membrane. Filtration of glomerulus forms 
relatively large volume of plasma ultra-filtrate 
(about 120 ml/minutes or 170 L/day). The 
ultra-filtrate will pass through tubules and 
undergo selective reabsorption. Distal end of 
glomerular capillaries merge and continue as 
efferent arterioles. Efferent arterioles will 
continue as second capillary networks 
(cortical peritubular capillaries or vasa recta 
medulla) around tubules. Efferent arterioles 
regulate hydrostatic pressure in both capillary 
networks.[4,8,9]  
Hydrostatic pressure along capillary 
walls of glomerulus is the main force of 
glomerular filtration. Oncotic pressure inside 
capillary lumens plays the role of filtration 
barrier. Oncotic pressure was influenced by 
unfiltered plasma protein concentration. 
During filtration process, oncotic pressure will 
increase along glomerular capillaries with the 
decrease of filtration pressure. It reaches 0 
mmHg in proximal of efferent arterioles. 
About 20% of plasma will be filtrated into 
Bowman capsules. Ratio of eGFR (estimated 
glomerular filtration rate) to renal blood flow 
determines filtration fraction.[4,9]  
Although glomerular filtration rate was 
affected by renal arterial pressure, but the 
relationship was not linier. It was because of 
autoregulation of GFR. Glomerular filtration 
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rate is the rate of blood that flows through 
nephrons after being filtered. GFR did not 
reflects general renal function and it could be 
affected by body surface area. GFR was 
calculated using some substances which were 
filtered entirely by glomerulus and were not 
reabsorbed by tubules, such as creatinine. 
Glomerular filtration pressure was constantly 
maintained under autoregulation process. It 
provided relatively constant glomerular 
filtration pressure under systemic blood 
pressure and cardiac output variation.[4,8]  
Rate of filtration and reabsorption in 
nephron was controlled by hormonal signals 
and hemodynamic factors. Those components 
were also important in blood pressure 
regulation. Juxtaglomerular part of kidney 
secreted renin as response to decrease of 
afferent arteriolar pressure, sympathetic 
nerve stimulations, and sodium concentration 
changes in distal contorted tubules at macula 
densa. Renin production is the first step of 
angiotensin II production and release of 
aldosterone which will continue to induce 
systemic vasoconstriction and regulate 
extracellular volume. Renin cleaved 
angiotensinogen into angiotensin I, in which it 
would be converted by angiotensin converting 
enzyme into angiotensin II. Angiotensin II will 
return the pressure of glomerular perfusion 
rapidly by vasoconstriction of efferent 
arterioles inside kidney and through systemic 
vasoconstriction. Both conditions will induce 
increase of kidney perfusion. In the long term, 
angiotensin II will increase plasma volume 
through stimulation of aldosterone release in 
which it will induce sodium reabsorption 
through renal tubules.[8,10]  
The increase of arteriolar afferent 
pressure will be accompanied by increase of 
urine output through the phenomenon of 
pressure diuresis. This condition will be 
reflected by renal urinary output curve or 
renal function curve. In artery pressure of 50 
mmHg, almost there is not any urinary output. 
In artery pressure about 100 mmHg, urinary 
output will be normal and in artery pressure of 
200 mmHg, the urinary output will be 8 times 
than normal. Increase of arterial pressure also 
increases sodium output through the process 
of pressure natriuresis.[10]  
Epidemiology and Etiology of Renal Artery 
Stenosis 
Prevalence of renal artery stenosis in 
general population is relatively small. About 1-
6% of patients with hypertension, was 
suspected to have element of renal artery 
stenosis. In population of patients that 
undergone coronary arteriography, the 
prevalence increased significantly to >20%. In 
a study of 1302 patients which undergone 
coronary arteriography, renal artery stenosis 
occurred in 15% of participants.[2,11]  
Renal artery stenosis is a spectrum of 
conditions with different pathophysiology, so 
it needs comprehensive approach of diagnosis 
and management. Generally, it is categorized 
as atherosclerotic and non-atherosclerotic 
renal artery stenosis. About 90% of renal 
artery stenosis was caused by atherosclerosis. 
Atherosclerosis often affects 1/3 proximal of 
renal artery stenosis, includes perirenal aorta 
and ostium. Non-atherosclerotic renal artery 
stenosis includes a large number of etiology 
such as fibromuscular dysplasia, aneurysm, 
arteriovenous fistulas, vasculitis, 
neurofibromatosis, trauma, emboli, congenital 
band, radiation therapy, and vascular 
dissection. Fibromuscular dysplasia is the 
second most common cause of renal artery 
stenosis, which about 10% of all renal artery 
stenosis. Although it was similar to vasculitis, 
definitive cause of fibromuscular dysplasia is 
still not known. [1,2] Table 1 presents some 
causes of renal artery stenosis. 
Table 1. Causes of Renal Artery Stenosis[1] 
Classification Causes 
Atherosclerotic Atherosclerosis 
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Diabetic nephropathy (small 
vessels) 
Renal thromboembolic disease 
Atheroembolic renal disease 
Aortorenal dissection 






Renal artery stenosis seldom generated 
major hemodynamic effects. Atherosclerotic 
renal artery stenosis often related to 
renovascular hypertension and nephropathy. 
Atherosclerotic renal artery stenosis was 
relatively common in population (6.8% in 
population >65 y.o) and the prevalence 
continues to increase with the increase of age. 
It was also commonly found in patient with 
other vascular diseases such as coronary 
artery disease (18-23%) and/or peripheral 
artery disease and lower extremity artery 
disease (>30%). More than 50% 
atherosclerotic renal artery stenosis will 
worsen in 5 years if it leaved without any 
treatment.[2,4] 
Fibromuscular dysplasia was reported 
in 3-5% of potential kidney donor candidate 
without any hypertensions. But this condition 
was also reported in young patient with 
hypertension (with age about 15-50 y.o.), 
especially women. FMD rarely disrupts kidney 
function but sometimes FMD causes total 
occlusion and renal artery aneurysm.[4,12]  
Pathophysiology of Renal Artery Stenosis and 
Clinical Manifestation 
Classically, renovascular diseases were 
classified into two broad groups, hypertension 
and nephropathy, in which both of them are 
related to renal artery stenosis.1 Severe 
unilateral renal artery stenosis would activate 
renin angiotensin aldosterone system (RAAS). 
It actually increased vasoconstriction and 
peripheral arterial resistance. If the 
contralateral kidney was normal without any 
stenosis, the effect of volume expansion would 
still be restricted by sodium and water 
excretion through contralateral kidney. But in 
the condition of bilateral renal artery stenosis, 
peripheral arterial resistance and blood 
volume continued to increase which lead to 
high blood pressure and overload 
condition.[3,4]  
Renin angiotensin aldosterone system 
has role in maintaining vascular tones, water-
sodium balance, and cardiac function through 
the interaction of sympathetic nervous system 
and some other hormones. The system will be 
activated in the condition of hypotension, 
decrease intravascular volume, hyponatremia, 
hypokalemia, and chloride changes. The 
system detects changes of intravascular 
volume through changes in Na-K-Cl co-
transporter at macula densa in kidney. 
Activated RAAS induces release of renin from 
juxtaglomerular apparatus inside kidney. 
Renin cleaves angiotensinogen into 
angiotensin I. Angiotensin I will be cleaved by 
angiotensin converting enzyme into 
angiotensin II. Angiotensin II binds to AT1 
receptor in the kidney. The binding induces 
cascades that will eventually causes 
vasoconstriction of efferent arterioles, 
aldosterone stimulation, and increase sodium 
reabsorption.[1,13]  
Renal artery stenosis progresses in a 
long period of time. It allows both kidneys to 
slowly adapt to decrease of blood flow through 
autoregulation.[3] Activated renin angiotensin 
aldosterone system aims to increase renal 
perfusion through systemic blood pressure 
rise. Beside vasoconstriction, water and 
sodium retention, aldosterone secretion, and 
sympathetic nerve activation, activated RAAS 
also induces vascular remodeling and 
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hypertension. Vasoconstriction in efferent 
arterioles of glomerulus will maintain 
glomerular filtration function in short time 
period and prevent kidneys from hypoxia. But 
in long period of time, RAAS will induce 
ischemic nephropathy in stenotic kidney, 
nephro-sclerotic hypertension in non-stenotic 
contralateral kidney, and glomerulosclerosis 
and interstitial fibrosis in both kidneys. 
Glomerulosclerosis and tubule-interstitial 
fibrosis was presumably due to increase of 
angiotensin II which related to increase of pro-
inflammatory cytokine, which in turn increase 
inflammatory and pro-fibrogenic pathway. In 
the condition of severe bilateral renal artery 
stenosis or stenosis in one functional kidney, 
kidney will losses its capacity to maintain 
balance of sodium and fails to induce pressure 
natriuresis against blood pressure increase. 
This will lead to inappropriate peripheral 
vasoconstriction with significant increase of 
afterload, which can lead to myocardial 
ischemia and heart failure.[1,5,9] 
 
Figure 1. Pathophysiology of renal artery stenosis [7] 
In an experimental study, significant 
hemodynamic changes that causes 
hypertension occurred in 75-80% of lumen 
occlusion. But critical point for lumen 
occlusion in human still could not be 
determined. Generally, stenosis for >50% or 
70% of lumen was defined as significant renal 
artery stenosis.[3]  
Hypertension in renal artery stenosis 
was also caused by some other mechanisms, 
such as increase sympathetic tones, 
endothelial dysfunction, oxidative stress, 
ischemic nephropathy, and end organ 
damage.[3] Overall, renal artery stenosis will 
cause systemic hypertension which indicated 
by dependencies to angiotensin in initial stage, 
wide range of blood pressure variation, losses 
of circadian blood pressure rhythm, and 
acceleration of end organ target damage, such 
as left ventricular hypertrophy and renal 
fibrosis.[4,13]  
Some recent studies oppose the idea of 
RAAS as the main factor played role in 
renovascular hypertension in renal artery 
stenosis. Studies using imaging technique 
showed that kidneys with arterial stenosis 
were not entirely hypoxic and even the 
stenotic kidney received higher blood flow 
than non-stenotic kidney. Studies also 
observed that kidneys had adaptation capacity 
to significant decrease of renal artery so they 
can maintain their oxygen capacity. Systemic 
RAAS activation tend to be temporarily but 
progress of kidney disease and cardiovascular 
dysfunction could happen without any 
persistent increase of angiotensin II. It 
indicated that even though systemic RAAS 
activation only last for a short period of time, 
but intra-renal RAAS activation was persistent 
because kidney could produce all elements 
needed in RAAS activation. Persistent RAAS 
activation occurred in stenotic kidney, but not 
in contralateral kidney.[7]  
Fibromuscular dysplasia (FMD) is often 
found in pre-menopausal women with age 
between 15-50 years old and it closely related 
to history of hypertension and smoking. FMD 
patients generally had good clinical condition 
with low cardiovascular risk. Hypertension in 
FMD did not related to obesity, oral 
contraception, and family history.[1] 
Histologically, FMD includes intimal, medial, 
and adventitial layer of renal artery, but 90% 
was found in medial layer. In angiography, 
FMD was described as beads-on-a-string 
because the contrast filled the aneurysm parts 
alongside renal artery. Most FMD causes 
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stenosis at 2/3 of distal renal artery. But it 
could also involve carotid and vertebral 
arteries. FMD had good prognosis and did not 
progress into total occlusion. But in 2/3 of 
patient, FMD is bilateral and causes 
renovascular hypertension, but rarely become 
nephropathy.[2,9]  
Pathologically, FMD had 3 subtypes:[2,4,6]  
a. Intimal fibroplasia: It encompasses 5-
10% of FMD and is often found in 
children and young adult. But it is not 
always found in women. Histologic 
examination showed collagen fibres 
deposit circularly at intimal layer 
which produced smooth tubular 
stenosis. 
b. Medial fibroplasia: It is the most 
common pathological finding in FMD 
(75-80%), which commonly found in 
middle aged women. There was the 
thinning of intimal and medial layer 
with losses of elastic lamina, which 
lead to aneurysm formation. The area 
of aneurysm was interspersed with 
local areas of fibrosis at medial layer. 
In angiography examination, those 
areas were referred as string of beads. 
One third of arteries were usually 
normal and 40% cases were bilateral.  
c. Perimedia fibroplasia: It is found in 
about 10% of FMD. Fibrosis tissue was 
formed in the outer layer of medial 
muscle layer. It causes severe stenosis 
without aneurysm.  
Atherosclerotic renal artery stenosis 
often happened in older individuals, in which 
7% was diagnosed in patient >65 years old 
and 60% was diagnosed in patient with 
history of hypertension, coronary artery 
disease, peripheral artery disease, and renal 
insufficiency. Atherosclerotic renal artery 
stenosis commonly involved artery ostia, 1/3 
proximal of renal artery, and nearby aorta. 
Atherosclerotic renal artery stenosis related to 
renovascular hypertension and 
nephropathy.[1]  
Renovascular hypertension in renal 
artery stenosis typically arise in young age and 
worsened with increasing age. It could also 
manifest as accelerated hypertension or 
resistant hypertension. Resistant 
hypertension is defined as uncontrolled 
hypertension despite consumption of 3 or 
more anti hypertension drugs including 
diuretics, or malignant hypertension with end 
organ damage.[8] Clinically, there could be 
some abdominal systolic or diastolic bruit and 
also hypokalemia in renovascular 
hypertension. Most common acute 
cardiovascular manifestation in renovascular 
hypertension includes flash pulmonary 
edema, which is not caused by any other 
coronary arterial diseases. Other 
cardiovascular manifestation includes 
hypertension related to acute coronary 
syndrome, aortic dissection, transient cerebral 
ischemia, stroke, intracranial hemorrhage, 
encephalopathy, and papil edema.[12]  
Renal manifestation of renal artery 
stenosis could include acute renal failure 
which was characterized by increase of 
creatinine level after consumption of ACE-
inhibitor or ARB. Acute renal failure typically 
happened in 10-14 days after first drug 
consumption, but occasionally it happened 
randomly. Although acute renal failure 
induced by ACE-inhibitor or ARB was 
considered as classic signs of renal artery 
stenosis, but it was not a sensitive nor specific 
indication for renal artery stenosis. Another 
renal manifestation is unreasonable chronic 
renal failure, asymmetrical renal size, and 
renal atrophy. About 5-15% of dialysis needed 
chronic ischemic nephropathy was estimated 
to be caused by renal artery stenosis.[1,12]  
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Diagnostic Criteria for Renal Artery Stenosis 
Renal artery stenosis is a general term 
for any vascular lesion which induced 
constriction of renal artery lumen and actually 
decrease renal blood flow. Two most common 
etiologies of renal artery stenosis are 
fibromuscular dysplasia and atherosclerotic 
renal artery stenosis. Atherosclerotic renal 
artery stenosis is typically accompanied by 
atherosclerosis in other arteries. Renal artery 
stenosis creates a wide spectrum of 
pathophysiology, with 3 main clinical 
syndromes: ischemic nephropathy, 
hypertension, and cardiac destabilization 
syndrome.[2]  
Diagnostic criteria for renal artery 
stenosis is not yet established, but there are 
some clinical conditions that can guide into the 
possibility of renal artery stenosis:[1,5]  
 Onset of hypertension <30 y.o. or severe 
hypertension in age >55 y.o. 
 Accelerated, resistant, or malignant 
hypertension 
 Renal atrophy without any defined causes 
or renal size discrepancies >1.5 cm 
 Flash pulmonary edema without any 
definitive causes 
 Unreasonable renal dysfunction, even 
need a renal replacement therapy 
 New azotemia or worsened of renal 
function after ACE inhibitor or ARB 
consumption 
 Multi-vessels coronary artery disease or 
peripheral artery disease 
 Congestive heart failure or refractory 
angina without any possible causes 
Patient with clinical suspicion of renal 
artery stenosis could have sent for diagnostic 
evaluation. Physical examination sometimes 
only gave limited clues such as 
systolic/diastolic abdominal bruit which 
radiated into flank area.[5] Prevalence of 
abdominal bruit was only about 78-87% even 
in patient with established renal artery 
stenosis. Systolic and diastolic bruit had 
sensitivity about 39% and specificity about 
99%. Epigastric bruit or flank bruit had 
sensitivity about 63% and specificity about 
90%.[6]  
Biochemical blood analysis indicated 
renal dysfunction with increase of creatinine 
level in serum and increase of plasma renin 
activity. Sometimes, renal dysfunction also 
caused hypokalemia due to 
hyperaldosteronism.[8] Urinary analysis 
showed increase urine concentration with 
decrease of sodium concentration, especially 
in kidney with ischemia. Estimated GFR will 
also lower in ischemic kidney.[9]  
Some diagnostic evaluation for renal 
artery stenosis includes captopril-stimulated 
nuclear renal flow, magnetic resonance 
angiography (MRA), and computerized 
tomography angiography (CTA). Captopril 
stimulated nuclear renal flow was used for 
diagnosing renal artery stenosis in patient 
with normal renal function and considered as 
one effective diagnostic method. But its 
accuracy decreased in patient with bilateral 
renal artery stenosis.[1]  
Table 2. Classification of Renal Artery Stenosis 




Physiologic testing Significance 
<50% None  Mild 
50-70% None Indeterminate 








50-70% with Renal Pd/Pa 0.8c Significant 
70% None Significant 
aVisual estimation 
bTranslesional gradient measured with a non-obstructive catheter, i.e. 4 
Fr or with 0.014-in pressure wire (Pd/Pa) 
cHyperemia may be induced with intrarenal bolus of papaverine 30 mg 
or dopamine at 50 g/kg  
Renal artery duplex ultrasonography 
(RADUS) is one of the sensitive and specific 
procedures for renal artery stenosis. It is not 
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expensive and can be repeated without any 
large risk. RADUS has sensitivity range about 
84-98% and specificity range about 97-99% 
according to studies from Taylor, et al. [14] and 
Olin, et al.[15] RADUS defined renal artery 
stenosis through the evaluation of ratio 
between peak velocity of renal artery systolic 
blood flow to peak velocity of aorta. But 
ultrasound has some limitation such as it 
depends on body habitus, bowel gas around 
kidney sometimes obscure kidney image, and 
the quality of examination depends on 
operator. To evaluate nephropathy in RADUS, 
clinician can use renal resistive index (RI) 
which is the evaluation of arterial flow 
resistance in the renal vascular networks and 
it is calculated using Doppler arterial 
pulsation. RI value >0.8 is considered 
significant for severe renal parenchymal 
disease.[1,5] Some other criteria evaluate renal 
artery stenosis using peak systolic velocity 
(PSV), renal aortic ratio (RAR), and 
acceleration time (AT) in RADUS. PSV value 
>180 cm/s is the most accurate diagnostic 
value for renal artery stenosis. Hemodynamic 
effect due to lumen occlusion such as changes 
of pressure trans-lesion or changes of flow 
trans-lesion, will be difficult to detect unless 
the occlusion is critical (occlusion of 70-80% 
of lumen).[6,15]  
Some axial imaging techniques such as 
CTA and MRA, also have high sensitivity and 
specificity for diagnosing renal artery stenosis, 
but with much higher cost. Although CTA has 
sensitivity about 94% and specificity about 
93%, CTA also possess high risk of contrast 
and radiation exposure.[5,6] MRA uses non-
ionic contrast and does not use radiation, but 
MRA is not recommended for only estimating 
the degree of severity. MRA has 90% of 
sensitivity and 94% of specificity. Patient with 
renal dysfunction has the risk of contrast 
induced nephropathy because of ionized 
contrast in CTA. Gadolinium contrast in MRA 
can induce nephrogenic systemic fibrosis.[16] 
Invasive angiography may be indicated in 
patient with inconclusive results of imaging 
and clinical manifestation of renal artery 
stenosis, especially in patient with indication 
of intervention and revascularization.  
In his review, Gottam, et al.[1] mentioned, 
with the sophistication of technology, some 
studies showed significant increase of 
sensitivity and specificity of CTA and MRA for 
renal artery stenosis. Study by Vasbinder, et 
al.[16] showed MRA sensitivity about 62%, CTA 
sensitivity about 64%, MRA specificity about 
84%, and CTA specificity about 94%.[16] In the 
studies by Postma et al17 and Williams, et al.[18] 
CTA showed sensitivity about 98% with 
specificity about 94% and MRA could show 
sensitivity as high as 100% and specificity 
about 96%.  
Renal angiography is the golden 
standard for invasive diagnostic evaluation for 
significant renal artery stenosis especially in 
patient with hemodynamic changes. Degree of 
stenosis was classified according to Table 2, 
but it did not accurately reflect clinically 
significant hemodynamic changes. Stenosis 
>70% was considered severe and significant 
hemodynamically. Stenosis between 50-70% 
might not be significant hemodynamically and 
it indicated repeated evaluation. Consensus 
and some experimental studies classified 
severe hemodynamic dysfunction if the 
average trans-lesion gradient was >10 mmHg, 
peak hyperemic systolic gradient pressure 
was >20 mmHg, or renal fraction flow reserve 
(FFR) 0.8.[5,18]  
Management of Renal Artery Stenosis 
The main objective of renal artery 
stenosis management is to prevent decrease of 
renal function and reduce water and sodium 
overload. Most patient with renal artery 
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stenosis had increase of mortality due to 
increase of cardiovascular dysfunction. 
Clinician had to ensure modification of 
changeable cardiovascular risk beside optimal 
management of renal artery stenosis.[9] 
Medical management is the main therapy of 
renal artery stenosis especially in 
atherosclerotic condition, in which patient 
was given oral anti hypertension, statin, and 
low dose aspilet.[8] Some studies also suggest 
diet, exercise and physical activity, and 
controlling other risk factors such as smoking 
and alcohol.[6] 
Conservative or medical management is 
indicated for patient with RI >80, pulse 
pressure >100, and severe nephropathy with 
urine protein excretion >1 g/day, creatinine 
clearance <40 ml/minute, hyperuricemia, and 
hypertension in nighttime. Some authors 
suggest pulse pressure >70.[1] Hypertension 
could be controlled with ACE inhibitor. But 
ACE-inhibitor might decrease renal perfusion 
which could be significant in post stenotic 
level. ACE inhibitor might also cause acute 
kidney injury in patient with 
hemodynamically significant bilateral renal 
artery stenosis.[9] Beside ACE inhibitor, other 
anti-hypertension which could be 
recommended is angiotensin receptor blocker 
(ARB).[7]  
When there is failure of conservative 
therapy in which the blood pressure did not 
come down, and accompanied by recurrent 
flash pulmonary edema, worsened azotemia, 
with evidence of significant renal artery 
stenosis, patient could be considered to be 
sent for revascularization. Revascularization 
should also consider about patient’s age and 
pulse pressure. Optimal outcome of 
revascularization decreases with increasing 
age.[1] Patient with pulse pressure <70 might 
still gain benefit from revascularization 
especially for blood pressure control with 
about 97% of sensitivity and specificity. 
Improvement of renal function has 80% 
sensitivity and 88% specificity. 
Revascularization in patient with pulse 
pressure >100 would even worsened blood 
pressure control with sensitivity about 73% 
and specificity about 99%. It would also 
decrease renal function with sensitivity about 
84% and specificity about 95%.[9,19]  
The main objective for revascularization 
is to improve blood pressure control, prevent 
progressive ischemic nephropathy, and 
improve heart failure, chronic angina or flash 
pulmonary edema. Revascularization is only 
indicated in hemodynamically significant 
renal artery stenosis. Table 3 shows some 
indications for revascularize-ation in renal 
artery stenosis.[5,9]  
Table 3. Indications of revascularization in renal 




renal artery stenosis 
 Recurrent congestive heart 
failure with undefined 
causes 
 Flash pulmonary edema 
without definitive causes 




Renal artery stenosis with 
 Accelerated, resistant, or 
malignant hypertension 
 Hypertension with 
unilateral kidney shrinkage 




Renal artery stenosis and 
chronic renal insufficiency 
Renal artery stenosis and 
chronic renal insufficiency with 
unilateral renal artery stenosis 
Asymptomatic unilateral or 
solitary viable kidney 
Asymptomatic unilateral 
significant renal artery stenosis 
but in only viable kidney 
Chronic renal failure with 
hemodialysis dependency 
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Progressive renal failure 
without definitive causes 
Main recommendation for FMD 
revascularization is balloon angioplasty. Some 
studies revealed successful outcome of 
balloon angioplasty for FMD with nearly 100% 
success rate with re-stenosis for only <10% in 
10 years. Angioplasty was proven to be more 
effective if the FMD was localized in major 
renal artery than diffused FMD. Some FMD 
cases were accompanied by aneurysm at renal 
artery in which if the aneurysm had big 
enough, it could be managed by graft stenting, 
occlusion with coil, or surgical 
reconstruction.[1,12]  
Diagnostic and Management Problem in 
Renal Artery Stenosis 
Fibromuscular dysplasia had some 
challenges in diagnostic process because 
although many patients showed symptoms 
and signs of resistant hypertension, but also 
many patients did not indicate any 
abnormalities in the physical examination and 
routine laboratory examination. Even RADUS 
was considered to be sensitive for diagnosing 
of renal artery stenosis, RADUS could produce 
false negative results in 10-20% of patient 
because of some confounding factors such as 
operator capability, obesity, or gas 
distribution at abdomen.[12,14] Other imaging 
technique such as CTA and MRA were 
sensitive and specific, but very expensive. CTA 
also poses risk of exposure to ionized contrast 
and radiation. MRA contrast, gadolinium, gives 
the risk of nephrogenic systemic fibrosis.[5,6] 
Therefore CTA was mostly recommended in 
patient with planning of revascularization. 
Some doubts were proposed regarding 
medical management for renal artery stenosis. 
Aggressive blood pressure control was 
considered to aggravate renal dysfunction, 
even though generally, blood pressure control 
could improve renal function with protecting 
contralateral kidney. Patient with medical 
management still had some risks to develop 
progressive renal dysfunction and 
cardiovascular events. Some studies observed 
inflammation reducing therapy may offer 
some benefit for some patients with chronic 
renal failure with renal artery stenosis.[7]  
Best result of revascularization was 
obtained in non-atherosclerotic FMD in which 
stenosis correction often improve blood 
pressure control and renal function. ASTRAL 
study revealed angioplasty and stenting may 
give some benefit for atherosclerotic renal 
artery stenosis but the evidence was still 
scarce regarding improvement of blood 
pressure control and renal function. 
Angioplasty and stenting, on other side, also 
had procedural risks such as renal artery 
occlusion, renal infarct, and 
atheroembolism.[8,23] Even 30% of renal 
intervention had complication because of 
atheroembolism. Recent studies mentioned 
renal artery stenting did not bring any 
significant benefit for preventing 
comorbidities such as cardiovascular event, 
renal disease progression, or the need of renal 
replacement therapy.[9,19]  
According to Tegtmeyer, et al.[25] 
angioplasty in FMD, although had better 
prognosis than atherosclerotic renal artery 
stenosis, only offered overall recovery rate 
about 36% with post-operative recovery rate 
about 54%. Re-stenosis rate for FMD was 20%. 
Another recent study in more than 2000 
patients, which recovery was defined as blood 
pressure <140/90 mmHg without any oral 
hypertension drugs, it was found that blood 
pressure outcome was significantly related 
with age.[28] Long term blood pressure control 
in FMD was about 93%. Improvement or 
stabilization of renal function was observed in 
about 92%. But complication of intervention 
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procedure in FMD was as high as 12% after 
angioplasty and 17% after surgery. Major 
complication was observed in 6% cases after 
angioplasty and 17% cases after surgery. 
Besides, medical management with oral anti 
hypertension was considered effective in FMD 
in which clinician seldom attempted 
intervention management.[9] But some authors 
found blood pressure control in FMD after 
revascularization was as high as 79% and 65% 
patient had successfully maintain blood 
pressure control until 8 years after 
revascularization.[1,29]  
Angioplasty with stent placement was 
more recommended for atherosclerotic renal 
artery stenosis to prevent elastic recoil, 
minimalize arterial dissection, and maximize 
lumen widening. Successful outcome of 
angioplasty with stent placement in 
atherosclerotic renal artery stenosis, although 
could be as high as 95-100%, but re-stenosis 
rate was also as high as 10-30% in 1-year 
period.[1] Procedural related complication was 
also high which included arterial dissection, 
atheroembolism, and renal dysfunction. Even 
with newest techniques such as catheter-in-
catheter and no-touch technique to 
minimalize contact between guiding catheter 
with atherosclerotic plaque, but renal 
embolism was found in 60% of cases and 
became the main major factor for worsening 
renal function.[30,31]  
There were three randomized clinical 
studies which compared angioplasty with 
medical management for blood pressure 
control in patient with renal artery stenosis. 
But none of those studies showed any 
significant differences in systolic blood 
pressure between 2 groups. Although 
DRASTIC study showed significant blood 
pressure improvement in angioplasty group 
than medical management group (68% vs 
38%) and angioplasty group showed fewer 
worsening of blood pressure control (9% vs 
33%) and fewer renal artery occlusion (0% vs 
16%) in 12 months.[29] But to date, there was 
not any study comparing medical 
management with angioplasty and stent 
placement because recently stent placement 
had become standard therapy. Stent 
placement in renal artery stenosis improved 
technical outcome and clinical outcome in long 
term period, compared to angioplasty alone, 
especially in ostial stenosis (80% of lumen). In 
a meta-analysis of 1.322 patients, stent 
placement had better technical outcome and 
lower re-stenosis rate when was compared to 
angioplasty alone (98% vs 77% and 17% vs 
26% respectively). It also offered higher 
recovery rate.[28]  
Stent placement in renal artery stenosis 
generally related to systolic and diastolic 
blood pressure improvement and decreased 
the need of oral anti hypertension. Even blood 
pressure improvement could be observed in 
24 hours after successful stent placement and 
maintained for 24 months. ASPIRE-2 study[26] 
evaluated safety and efficacy of balloon 
expandable stent placement after failure of 
angioplasty. It revealed re-stenosis in 17.4% of 
participants. Some predictors for re-stenosis 
in the study was diabetes, pre-procedural 
small diameter of vessels, and small minimum 
diameter of vessel after procedure. But this 
study also found the increase of average 
creatinine level from 1.360.52 mg/dl in 
baseline to 1.400.61 mg/dl in 9 months and 
became 1.460.81 mg/dl in 24 months. In a 
subgroup of patient with baseline creatinine 
level 1.460.81 mg/dl, there was increase of 
creatinine to 1.460.81 mg/dl in 9 months and 
1.460.81 mg/dl in 24 months. In 24 months, 
7.5% of patient with abnormal renal function 
at baseline, had worsening of renal function 
although there were not any patients 
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requiring permanent nor temporary 
hemodialysis. 
CORAL study [28] compared optimal 
medical management with angioplasty and 
stent placement in patient with 
hemodynamically significant atherosclerotic 
renal artery stenosis and refractory systolic 
hypertension. Stent placement used distal 
protection. Optimal medical management 
included aggressive hypertension 
management, dyslipidemia management, 
diabetes, chronic kidney disease, smoking 
cessation, and anti-platelet drugs. Primary 
outcome for study was cardiovascular event or 
major renal dysfunction and death which 
related to cardiovascular event, renal 
dysfunction, stroke, myocardial infarction, 
hospitalization due to congestive heart failure, 
and the need of permanent renal replacement 
therapy. Primary outcome did not significantly 
differ between medical management group 
and stent group with hazard ratio 0.94 (35.8 
vs 35.1%). Mortality rate was also not 
significantly different. Systolic blood pressure 
decreased in both groups with higher decrease 
in stent group (average -2.3 mmHg).[30]  
ASTRAL study[27] compared 
revascularization therapy and optimal 
medical management. This study showed 
higher rate of renal dysfunction in medical 
therapy group with difference about 
0.06x103/L every year. Average creatinine 
serum concentration was 1.6 mol/L lower in 
patient with revascularization compared to 
medical therapy group. Systolic blood 
pressure was not significantly different 
between two groups but diastolic blood 
pressure had higher decrease in medical 
therapy group. But in this study, renal event 
(hazard ratio 0.97), cardiovascular event 
(hazard ratio 0.94), and mortality rate (hazard 
ratio 0.90) was equivalent between two 
groups.  
In STAR study[30], authors observed the 
efficacy and safety of stent placement in 
patient with renal artery stenosis and 
decrease of renal function, compared to 
medical therapy management. Primary 
outcome in this study was the decrease of 
creatinine clearance 20% or more from 
baseline with two measurement. In stent 
group, if the primary outcome has been 
achieved, patient was sent for imaging 
examination to exclude re-stenosis of renal 
artery. Primary outcome was achieved in 22% 
of medical therapy patient and 16% of stent 
patient in 10 months. 5 from 10 patients in 
stent group had repeated angioplasty before 
they could achieve primary outcome in which 
2 of them had re-stenosis. This study also 
indicated there was not any significant 
difference for blood pressure control, 
cardiovascular morbidity and mortality, and 
incidence of worsening renal function.[31]  
True renovascular hypertension 
occurred when hypertension caused by renal 
artery stenosis induced activation of renal 
angiotensin aldosterone system. This 
condition happened when the blood pressure 
did not improve after renal revascularization. 
It became special problem in diagnostic 
procedure because if the blood pressure did 
not improve after revascularization, patient 
might have renovascular hypertension or 
might be there were structural changes that 
prevent blood pressure from falling. Patient 
might also have essential hypertension 
accompanied by atherosclerotic renal artery 
stenosis with or without renovascular 
component. Renovascular hypertension could 
only happened in the condition of renal artery 
stenosis, but renal artery stenosis could occur 
without any renovascular hypertension.[3] 
Some studies showed failure of 
revascularization to improve clinical condition 
and anatomical diameter could not be used as 
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prognostic factor in revascularization.[19,20,21] 
Other studies used pressure gradient as 
predictor of significant stenosis in which 
fractional flow reserve <0.80 might be a good 
response predictor to revascularization.[31]  
Gottam, et al. [1] mentioned that although 
renal artery stenosis was assumed to improve 
with revascularization and revascularization 
would also improve renovascular 
hypertension and nephropathy according to 
their pathophysiology, but some clinical 
studies did not always observe those same 
facts. Reasons behind those phenomena were 
complex and many studies is still on going to 
reveal many more of those reasons. Some 
process which could be related to 
hypertension after revascularization were 
sympathetic activation and endothelial 
dysfunction.[3] Recent evidences indicated 
improvement of blood flow alone could not 
improve outcome of renal function and 
cardiovascular event in patient with renal 
artery stenosis.[11]  
C O N C L U S I O N 
Current problem regarding renal artery 
stenosis was dilemma in diagnostic process 
and management. To date there was not any 
specific diagnostic criteria for renal artery 
stenosis. Some authors only suggest clinical 
suspicion which could possibly guide the 
diagnosis of renal artery stenosis. RADUS as 
one sensitive and specific procedure for 
diagnosing renal artery stenosis, sometimes 
was still confounded by some confounding 
factors. Imaging techniques such as CTA and 
MRA were excellent in diagnosing renal artery 
stenosis, but they were expensive and 
possessed the risk of ionized contrast and 
radiation exposure. To define severity of 
stenosis, clinician might use RADUS with and 
followed by CTA in some cases. But CTA was 
more recommended to performed in patient 
with planning of revascularization. 
Clinical outcome for revascularization 
was best found in fibromuscular dysplasia 
with the using of balloon angioplasty, with 
success rate almost 100% with blood pressure 
control rate about 93%. But complication rate 
of the procedure was still as high as 12% after 
angioplasty and 17% after surgery, that 
included arterial dissection, atheroembolism, 
and renal infarction. Some studies even 
showed equivalent effectivity of conservative 
medical therapy and angioplasty so the 
angioplasty was not recommended unless 
medical therapy had failed. In atherosclerosis, 
even though success rate of stenting achieved 
95-100%, but re-stenosis rate was 10-30% in 
1 year.[1] Revascularization procedure could 
not entirely improve renovascular 
hypertension and nephropathy because they 
had complex mechanisms and improvement of 
renal blood flow alone could not ameliorate 
renal function nor cardiovascular event. From 
clinical studies, it was still recommended to 
choose revascularization in FMD, but 
revascularization should only be performed 
after the failure of optimal medical 
management in atherosclerotic renal artery 
stenosis 
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